readthroughSign in
CompanyZNTLNasdaqSan Diego, CA

Zentalis Pharmaceuticals, Inc.

Zentalis develops azenosertib, a WEE1 inhibitor in clinical development for ovarian cancer and multiple tumor types.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story